Incidence of malignant tumours in relatives of BRCA1 and BRCA2 germline mutation carriers.

[1]  Å. Borg,et al.  BRCA2 germ-line mutations are frequent in male breast cancer patients without a family history of the disease. , 1998, Cancer research.

[2]  J Chang-Claude,et al.  Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.

[3]  N. Nelson.  Another taxane takes center stage in San Antonio. , 1998, Journal of the National Cancer Institute.

[4]  W. Foulkes,et al.  Is hereditary site-specific ovarian cancer a distinct genetic condition? , 1998, American journal of medical genetics.

[5]  D E Goldgar,et al.  Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. , 1997, American journal of human genetics.

[6]  P. Hartge,et al.  The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. , 1997, The New England journal of medicine.

[7]  Å. Borg,et al.  Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer. , 1997, American journal of human genetics.

[8]  E. Thomson,et al.  Recommendations for follow-up care of individuals with an inherited predisposition to Cancer. II. BRCA1 and BRCA2 , 1997 .

[9]  E. Thomson,et al.  Recommendations for Follow-up Care of Individuals With an Inherited Predisposition to Cancer: I. Hereditary Nonpolyposis Colon Cancer , 1997 .

[10]  Å. Borg,et al.  Tumour biological features of BRCA1-induced breast and ovarian cancer. , 1997, European journal of cancer.

[11]  C. Moskaluk,et al.  Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. , 1996, Cancer research.

[12]  D. B. Berman,et al.  Frequency of recurrent BRCA1 and BRCA2 mutations in Ashkenazi Jewish breast cancer families , 1996, Nature Medicine.

[13]  T. Katagiri,et al.  Mutations in the BRCA2 gene in hepatocellular carcinomas. , 1996, Cancer research.

[14]  D. Schaid,et al.  Allelic imbalance and microsatellite instability in prostatic adenocarcinoma. , 1996, Cancer research.

[15]  P. Laurent-Puig,et al.  Segregation of two BRCA1 mutations in a single family. , 1996, American journal of human genetics.

[16]  J. Eyfjörd,et al.  A single BRCA2 mutation in male and female breast cancer families from Iceland with varied cancer phenotypes , 1996, Nature Genetics.

[17]  C. Larsson,et al.  Mutation analysis of the BRCA2 gene in 49 site–specific breast cancer families , 1996, Nature Genetics.

[18]  M. King,et al.  Novel inherited mutations and variable expressivity of BRCA1 alleles, including the founder mutation 185delAG in Ashkenazi Jewish families. , 1995, American journal of human genetics.

[19]  P. Tonin,et al.  A large multisite cancer family is linked to BRCA2. , 1995, Journal of medical genetics.

[20]  J. Gudmundsson,et al.  Different tumor types from BRCA2 carriers show wild-type chromosome deletions on 13q12-q13. , 1995, Cancer research.

[21]  M. Stratton,et al.  A 45-year follow-up of kindred 107 and the search for BRCA2. , 1995, Journal of the National Cancer Institute. Monographs.

[22]  D. Easton,et al.  Breast and ovarian cancer incidence in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. , 1995, American journal of human genetics.

[23]  D. Easton,et al.  Risks of cancer in BRCA1-mutation carriers , 1994, The Lancet.

[24]  R. Barkardottir,et al.  Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. , 1993, American journal of human genetics.

[25]  D. Easton,et al.  Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium. , 1993, American journal of human genetics.